Efficacy And Tolerance Of Metronidazole And Miconazole Nitrate In Treatment Of Vaginitis.
F. Peixoto, A. Camargos, Geraldo Duarte, I. Linhares, L. Bahamondes, A. Petracco
Published 2008 · Medicine
Download PDFAnalyze on Scholarcy
OBJECTIVE To evaluate the efficacy and tolerability of a vaginal pessary containing 750 mg of metronidazole and 200 mg of miconazole nitrate used daily for 7 days in the treatment of vaginitis. METHODS Ninety-two women with vaginitis participated in this phase 3 study using one vaginal pessary daily for 7 days. Gynecological and microbiological evaluations were carried out prior to and following treatment. RESULTS Reductions occurred in symptoms and signs of vaginitis. Clinical cure rate was 87.7%, while the cure rates according to microscopy and Candida albicans culture were 81.8% and 73.9%, respectively. The cure rate for bacterial vaginosis was 75% and culture of Gardnerella vaginalis turned negative in 63.6% of cases following treatment. The medication was well tolerated. CONCLUSION Use of a combination of 750 mg of metronidazole and 200 mg of miconazole in a single daily application was found to be effective in the treatment of the most common causes of vaginitis.
This paper references
Predictive value of the clinical diagnosis of lower genital tract infection in women.
D. Landers (2004)
ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis.
Diagnosis of vaginitis.
M. Egan (2000)
Trichomoniasis: under control or undercontrolled?
D. Soper (2004)
Vaginal discharge—causes, diagnosis, and treatment
H. Mitchell (2004)
Diagnostic microbiology of bacterial vaginosis.
S. Hillier (1993)
Diagnostic Criteria and Microbial and Epidemiologic Associations
R. Amsel (1983)
Treatment of vaginitis.
Ş. Kükner (1996)
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy.
J. Hanson (2000)
Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.
M. Joesoef (1999)
Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran) - a triple-active pessary for the treatment of single and mixed vaginal infections.
E. Ozyurt (2001)
ACOG PRACTICE BULLETIN
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.
J. Sobel (2006)
Metronidazole for Bacterial Vaginosis
J. M. Hanson (1986)
Sexually transmitted diseases treatment guidelines
G. Burstein (2003)
Vulvovaginitis: aspectos habitualmente näo considerados
P. Giraldo (1997)
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.
R. Amsel (1983)
The limited value of symptoms and signs in the diagnosis of vaginal infections.
V. Schaaf (1990)
Evaluation of vaginal complaints.
M. Anderson (2004)
The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth.
R. Goldenberg (2006)
Epidemiology of vaginitis.
H. L. Kent (1991)
Management of vaginitis.
Marion K Owen (2004)
A comparative clinical evaluation of econazole nitrate, miconazole, and nystatin in the treatment of vaginal candidiasis.
F. Emele (2000)
Managing recurrent bacterial vaginosis
J. Wilson (2004)
Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days.
D. Upmalis (2000)
What's new in bacterial vaginosis and trichomoniasis?
J. Sobel (2005)
Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
D. Brown (1999)
Neotran® – A New Double-Active Pessary for the Treatment of Vaginitis
O. Morton (1993)
The diagnosis and treatment of infectious vaginitis
L. Edwards (2004)
This paper is referenced by
Lithiation and functionalization of 1-alkynylimidazoles at the 2-position
C. Laroche (2009)
Drug Delivery Systems for Vaginal Infections
S. Borges (2016)
Investigation of sustained release mucoadhesive in-situ gel system of Secnidazole for the persistent treatment of vaginal infections
R. Karthick (2018)
NOVEL DOSAGE FORM TARGETING VAGINAL ADMINISTRATION
Ming-Kuang Shih (2013)
Quercus Brantii Lindl. Vaginal Douche Versus Clotrimazole on Vaginal Candidiasis
Zeinab Moshfeghy (2018)
Comparing the Effect of Propolis Vaginal Cream and Metronidazol Vaginal Gel for Treatment of Bacterial Vaginosis
Mahsa Sadat Mousavi (2016)
Prognostic Indicators of Recurrence of Bacterial Vaginosis
J. Sobel (2019)
Comparison of the Effect of Vaginal Zataria multiflora Cream and Oral Metronidazole Pill on Results of Treatments for Vaginal Infections including Trichomoniasis and Bacterial Vaginosis in Women of Reproductive Age
K. Abdali (2015)
Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents
Nhung T. T. Dang (2013)
Nifuratel‐Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis
J. Obiero (2018)
High-Dose Vaginal Metronidazole for Recurrent Bacterial Vaginosis—A Pilot Study
Tina J Aguin (2014)
Clindamycin, Clotrimazole and Tinidazole in Mixed Vaginosis- A "Real World" Clinical Experience
Manish Maladkar (2015)
Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies
Michael D. Harwich (2010)
Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses
Jack D. Sobel (2019)
Formulation and evaluation of mucoadhesive vaginal gel containing novel combination of metronidazole and miconazole nitrate for the treatment of vaginitis
Dhanashree Arun Mundhey (2015)